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Abstract
Aims/hypothesis Chronically elevated blood glucose (hyper-
glycaemia) is the primary indicator of type 2 diabetes, which
has a prevalence that varies considerably by ethnicity in the
USA, with African-Americans disproportionately affected.
Genome-wide association studies (GWASs) have significant-
lyenhanced our understanding ofthe genetic basis of diabetes
and related traits, including fasting plasma glucose (FPG).
However, the majority of GWASs have been conducted in
populations of European ancestry. Thus, it is important to
conduct replication analyses in populations with non-
European ancestry to identify shared loci associated with
FPG across populations.
Methods We used data collected from non-diabetic unrelated
African-American individuals (n=927) who participated in
the Howard University Family Study to attempt to replicate
previously published GWASs of FPG. Of the 29 single
nucleotide polymorphisms (SNPs) previously reported, we
directly tested 20 in this study. In addition to the direct test,
we queried a 500 kb window centred on all 29 reported
SNPs for local replication of additional markers in linkage
disequilibrium (LD).
Results Using direct SNP and LD-based comparisons, we
replicated multiple SNPs previously associated with FPG
and strongly associated with type 2 diabetes in populations
with European ancestry. The replicated SNPs included
those in or near TCF7L2, SLC30A8, G6PC2, MTNR1B,
DGKB-TMEM195 and GCKR. We also replicated addition-
al variants in LD with the reported SNPs in ZMAT4 and
adjacent to IRS1.
Conclusions/interpretation We identified multiple GWAS
variants for FPG in our cohort of African-Americans. Using
an LD-based strategy we also identified SNPs not previ-
ously reported, demonstrating the utility of using diverse
populations for replication analysis.
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Genome-wide association studies (GWASs) have significant-
ly added to our understanding of the genetic basis of type 2
diabetes and related traits, including fasting plasma glucose
(FPG), by identifying a number of genes potentially involved
in the pathophysiology of this common complex disease [1].
However, the majority of FPG GWASs have been conducted
in individuals of European descent, many of which were
included in a recent meta-analysis [2]. While this informa-
tion has laid an important foundation, it is important to
investigate whether identified loci transfer across populations
with different ancestral backgrounds [3] and whether novel
variants could be identified as recently demonstrated in
populations of East Asian and Indian backgrounds [4, 5].
Here, we conducted replication of published GWAS results
for FPG in African-Americans from the metropolitan area of
Washington DC, USA.
Methods
Ethics statement Ethical approval for the Howard Univer-
sity Family Study (HUFS) was obtained from the Howard
University Institutional Review Board and written informed
consent was obtained from each participant.
Study design The individuals studied were unrelated non-
diabetic participants over the age of 20 years (n=927)
enrolled in the HUFS. This population-based study of
African-Americans in the Washington, DC metropolitan
area has been previously described by Adeyemo et al. [6].
For the present study, participants with FPG ≥7 mmol/l or
who were receiving treatment for diabetes were excluded.
Additional characteristics of the cohort can be found in
Electronic supplementary material (ESM) Table 1.
Genotyping All 927 DNA samples were prepared and
genotyped as described by Adeyemo et al. [6]. Briefly, all
samples passed a sample success rate of 95%. Single
nucleotide polymorphisms (SNPs) were excluded if they
had a success rate of less than 95% (41,885 SNPs excluded),
a minor allele frequency (MAF) ≤0.01 (19,154 SNPs
excluded), or had a p value for the Hardy-Weinberg test of
equilibrium <10
−3 (6,317 SNPs excluded). The current
analysis focuses on the 808,465 autosomal SNPs that passed
these filters. In addition, imputation was performed as
reported by Shriner et al. [3]. We successfully imputed
1,506,100 SNPs using the Yoruba in Ibadan, Nigeria (YRI)
reference panel and an additional 52,291 SNPs using the
Centre d’Etude du Polymorphisme (Utah residents with
northern and western European ancestry) (CEU) reference
panel, for a total of 2,366,856 experimentally determined
and imputed SNPs.
Statistical analyses FPG was log-transformed and values
greater than ±3 SDs from the mean value were winsorised
(n=8). All regression models were adjusted for age, sex,
BMI and one EIGENSTRAT axis under an additive model.
In separate analyses, hypertension was also adjusted for the
known association with insulin resistance [7], but the effect
was inconsistent, with the magnitude of the p value
marginally increasing or decreasing significance for some
SNPs (data not shown).
Replication analysis was performed on SNPs identified
in GWASs of FPG based on information in the National
Human Genome Research Institute’s catalogue of published
GWASs (www.genome.gov/gwastudies/). The query
returned hits indicating reported SNPs, their respective
p values and associated genes (ESM Table 2). If multiple
studies reported the same SNP, the SNPs with the lowest
p value were included in the present study. The returned
results included 16 SNPs associated with FPG in the Meta-
Analyses of Glucose and Insulin-related traits Consortium
(MAGIC) study [2]. The MAGIC SNPs were supplemented
by 13 additional SNPs from previously published GWASs
(ESM Table 2) for a total of 29 SNPs that we attempted to
replicate in our African-American cohort.
Our replication effort occurred in two stages. In the first
stage, we attempted to replicate 20 of the 29 exact
published SNPs (i.e. direct replication) available in the
HUFS dataset. For this stage, SNPs were considered
replicated if the same HUFS SNP had a p value <0.05.
For the second stage, we performed a local replication
analysis based on a 500 kb linkage disequilibrium (LD)
block containing a query SNP determined by the SNPs
most distant from the query SNP with r
2≥0.3. We used the
HapMap CEU LD data (http://hapmap.ncbi.nlm.nih.gov/
downloads/ld_data/2008-06/00README.TXT)f o ra l l
SNPs except for rs2166706 where the Gujarati Indians
in Houston, Texas, USA (GIH) reference dataset (http://
hapmap.ncbi.nlm.nih.gov/downloads/ld_data/2008-09_
phaseIII/00README.txt) was used to match the original
reported GWAS population [5]. Second, we estimated
the covariance matrix for the block of SNPs using the
HUFS genotype data. Third, the covariance matrix was
spectrally decomposed and the effective degrees of
freedom, Neff, were estimated using the relationship
Neff ¼
P K
k¼1
lk
   2
=
P K
k¼1
l2
k
  
,i nw h i c hλk is the kth eigenvalue
of the K×K covariance matrix for the K SNPs [8]. Fourth,
the nominal significance threshold α=0.05 was divided by
Neff.
Power calculations were carried out using the Quanto
software package (Version 1.2.3, http://hydra.usc.edu/gxe/).
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independent individuals design; and a gene-only hypothesis.
An additive inheritance model was applied for varying
MAFs. MAFs were calculated based on HUFS data; for
SNPs with no associated HUFS data, HapMap- or Perlegen-
reported MAFs were used. The power for the present study
was determined based on reported effect estimates for FPG
for each reported MAGIC SNP [2].
Results
Of the 16 SNPs recently reported in the MAGIC meta-
analysis of over 122,000 participants [2], 12 were available
for testing in the HUFS dataset (ESM Table 2). We directly
replicated three SNPs (rs2191349, rs11558471 and
rs4506565) located in or near DGKB-TMEM195, SLC30A8
andTCF7L2 genes respectively (Table 1). We also replicated
SNPs from other GWASs for FPG: rs2722425 within
ZMAT4 (p value=0.024) as well as rs625643 (p value=
0.048), which is located in a functionally unknown region on
chromosome 1 (Table 1). SNPs from the remaining studies
that did not directly replicate are not shown. We note that
SNPs in C2CD4B, FADS1, GCK and G6PC2 from the
MAGIC study and IRS1, PDE4B,a n dATP8B4 from other
GWASs were not directly compared in the HUFS dataset
owing to quality-control filters or lack of genotyping or
imputation data.
We also analysed SNPs that were in LD (r
2≥0.3) with
each discovery SNP (ESM Fig. 1). This replication strategy,
which queried a 500 kb window centred on the index SNP,
yielded a total of 317 SNPs located in or near nine different
genes or unknown gene region (G6PC2, GCKR, MTNR1B,
DGKB-TMEM195, TCF7L2, SLC30A8, AK024684, ZMAT4
and IRS1). Thirty-eight SNPs distributed across all nine
gene regions of the 317 SNPs tested were significantly
associated with FPG after Bonferroni correction for
multiple comparisons (Table 2).
Based on reported effect sizes of the 14 MAGIC loci
(excluding TCF7L2 and SLC30A8), the power was calcu-
lated for each SNP using the African-American MAFs
where available (ESM Table 3). The estimated power for
this study ranged from a low of 0.25 to a high of 0.99. The
SNPs in the four genes most strongly powered (i.e. > 90%
power) in this study were either directly replicated (DGKB-
TMEM195) or locally replicated (G6PC2, MTNR1B and
GCKR) with markers in moderate LD (r
2≥0.4). The effect
sizes for SNPs rs4506565 and rs11558471 (previously
reported loci TCF7L2 and SLC30A8, respectively) were not
reported in the MAGIC study.
Table 1 SNPs that were reported in the MAGIC study and other GWASs of FPG that were directly analysed for replication in a cohort of
African-Americans (the HUFS)
SNP Nearest gene Region Position Reported p value HUFS
Allele
(effect/other)
β p value
HUFS
rs340874 PROX1 1q41 212225879 7.1×10
−8 C/T −0.0124 0.191
rs780094 GCKR 2p23.2 27594741 2.5×10
−12 T/C 0.0034 0.66
a
rs11708067 ADCY5 3q13.33 124548468 8.7×10
−9 G/A −0.0028 0.73
a
rs11920090 SLC2A2 3q26.2 172200215 1.9×10
−6 A/T 0.0001 1.0
rs2191349 DGKB-TMEM195 7p21.2 15030834 7.8×10
−17 G/T −0.0136 0.023
b
rs11558471 SLC30A8 8q24.11 118254914 2.6×10
−11 G/A −0.0255 0.0074
b
rs7034200 GLIS3 9p24.2 4279050 1.2×10
−4 C/A 0.0056 0.35
rs10885122 ADRA2A 10q25.2 113032083 8.4×10
−11 G/T 0.0079 0.2
rs4506565 TCF7L2 10q25.2 114746031 1.2×10
−8 T/A −0.0117 0.036
a,b
rs10830963 MTNR1B 11q21 92348358 1.2×10
−68 G/C −0.0046 0.67
a
rs11605924 CRY2 11p11.2 45829667 1.5×10
−9 C/A 0.0048 0.57
rs7944584 MADD 11p11.2 47292896 1.5×10
−9 T/A 0.0026 0.84
a
From other FPG GWASs
rs625643 AK024684 1p32.3 54409755 4.0×10
−3 T/C 0.01141 0.05
a,b
rs2722425 ZMAT4 8p11.21 40603396 9.0×10
−6 T/C 0.01326 0.024
b
aGenotyped HUFS SNPs (all other SNPs were imputed)
bSNPs from reported studies that are also statistically significant (p<0.05) in the HUFS dataset
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2≥0.3) with reported SNPs from the MAGIC study
and other GWASs of FPG
Region Nearest gene Reported SNP in LD Study results
SNP p value Allele
(effect/other)
β r
2 p value df
a Corrected
p value
HUFS
2q31.1 G6PC2 rs560887 4.4×10
−35 rs575671 A/G −0.0185 0.50 0.003 2.76 0.01
2p23.2 GCKR rs780094 2.5×10
−12 rs780100 G/T 0.0142 0.46 0.020 2.55 0.05
rs704791 T/C 0.0142 0.46 0.020 2.55 0.05
rs780102 T/C 0.0142 0.46 0.020 2.55 0.05
rs704795 G/A 0.0154 0.46 0.011 2.55 0.03
rs10208529 T/A −0.0198 0.54 0.021 2.55 0.05
7p21.2 DGKB-TMEM195 rs2191349 7.8×10
−17 rs2215383 T/C −0.0175 1.0 0.003 2.38 0.007
rs10244051 T/G −0.0163 1.0 0.004 2.38 0.01
rs10258074 A/T −0.0163 0.97 0.004 2.38 0.01
rs2191348 G/T −0.0164 1.0 0.004 2.38 0.009
rs6947830 G/A −0.0131 1.0 0.022 2.38 0.05
b
rs4719433 T/C −0.0131 1.0 0.022 2.38 0.05
b
rs1974620 C/T −0.0147 0.97 0.011 2.38 0.03
b
rs1558317 T/A −0.0147 0.96 0.011 2.38 0.03
rs1558318 A/T −0.0147 0.97 0.011 2.38 0.03
8q24.11 SLC30A8 rs11558471 2.6×10
−11 rs11774700 C/T −0.0249 0.78 0.004 1.74 0.006
10q25.2 TCF7L2 rs4506565 1.2×10
−8 rs7901695 C/T −0.0127 0.88 0.022 1.72 0.04
11q21 MTNR1B rs10830963 1.2×10
−68 rs1447350 C/G −0.0141 0.43 0.014 2.46 0.03
rs1447351 A/G −0.0131 0.43 0.022 2.46 0.05
rs4611171 T/G −0.0131 0.42 0.022 2.46 0.05
b
rs1597023 G/A −0.0131 0.42 0.022 2.46 0.05
rs4406791 A/C −0.0131 0.42 0.022 2.46 0.05
rs1447352 G/A −0.0131 0.43 0.022 2.46 0.05
rs9666752 G/A −0.0148 0.36 0.009 2.46 0.02
From other FPG GWASs
1p32.1 AK024684 rs625643 4×10
−3 rs671431 G/C 0.0143 0.62 0.022 1.66 0.04
2q36.1 IRS1 rs2943641 5×10
−2 rs6713510 A/T 0.0169 0.43 0.005 5.13 0.03
rs4072096 G/A 0.0171 0.43 0.005 5.13 0.03
rs4645008 A/C 0.0181 0.43 0.003 5.13 0.02
rs2943644 T/C 0.0181 0.41 0.003 5.13 0.02
rs2943633 C/T 0.0167 0.45 0.005 5.13 0.03
rs2972150 C/A 0.0161 0.45 0.007 5.13 0.04
rs2943636 C/T 0.0165 0.45 0.006 5.13 0.03
rs2972149 A/G 0.0201 0.50 0.0007 5.13 0.004
b
rs1515114 A/T 0.0196 0.60 0.0009 5.13 0.005
b
rs2722429 G/A 0.0186 0.60 0.001 5.13 0.006
8p11.21 ZMAT4 rs2722425 9×10
−6 rs1823643 T/C 0.0192 0.89 0.002 1.53 0.007
C/A 0.0145 0.65 0.021 1.53 0.03
b
C/T 0.0146 0.68 0.018 1.53 0.03
adf calculated from covariance matrix of SNPs in LD (r
2 ≥0.3) with query SNP in 500 kb window; df were used for Bonferroni corrections
bGenotyped HUFS SNPs (all other SNPs were imputed)
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Chronically elevated FPG is a primary indicator of diabetes,
making it an important barometer of the progression of
impaired glucose metabolism. In this paper, we attempted
to replicate, in nearly 1,000 African-Americans, significant
GWAS loci for FPG in populations of predominantly
European ancestry. In light of well-reported increased genetic
diversity in populations with African ancestry [9, 10], our
replication strategy not onlyfocused onthe reportedSNPs but
alsoincludedqueryingvariants inLDwiththereportedSNPs.
We focused our replication analysis on the MAGIC
study of over 122,000 participants to identify FPG-
associated SNPs shared across ethnically diverse popula-
tions. In addition, we included SNPs from prior GWASs of
FPG to add breadth to our replication pool, keeping in mind
that potential differences in susceptibility loci between
populations may exist [11]. Of the 12 SNPs reported by the
MAGIC study that were directly testable in our African-
American cohort, we replicated three SNPs within DGKB-
TMEM195, TCF7L2 and SLC30A8. We also replicated
SNPs in ZMAT4, which encodes a zinc finger, matrin type 4
protein identified in previous GWASs but not replicated in
the MAGIC meta-analysis. Using the local (LD-based)
replication strategy, we replicated additional SNPs in or
near previously reported genes, including the insulin
receptor substrate 1 gene.
Interestingly, comparison of the LD structure in HUFS to
HapMap reference samples CEU and YRI supports the
utility of African-American population samples in refining
association loci. For example, the covariance matrix
generated for the local replication of rs625643 spans
40 kb and includes 16 SNPs. In HapMap CEU, nearly the
entire region is in moderate LD, whereas in HapMap YRI
two distinct LD blocks are observed (ESM Fig. 2) and
lower (on average) r
2 values are observed between
rs625643 and downstream SNPs (0.78 for CEU and 0.5
for YRI). As expected, African-American samples (i.e.
HapMap African Ancestry in Southwest, USA [ASW] and
this study HUFS) show an LD structure intermediate to
CEU and YRI (ESM Fig. 3 and ESM Fig. 2). Furthermore,
given the association signals in HUFS, a case can be made
for a narrowing of the region of interest from 40 kb to 3 kb
between the locally replicated SNP rs671431 and the
original discovery SNP (ESM Fig. 3).
We acknowledge the fluid interpretation of r
2 values
within the context of establishing variants in LD with each
other as well as the concern of being overly conservative in
our correction for multiple comparisons. At an r
2≥0.3, we
attempted to first capture a significant portion of SNPs in
LD within the reference sample while maintaining confi-
dence in the ability of related SNPs to serve as proxies [12].
In addition, a blanket search window of 500 kb would
allow for capture of some unique characteristics of LD and
long-range LD associated with admixed populations such
as African-Americans [13]. To address the burden of
potentially overcorrecting for multiple comparisons, our
Bonferroni correction strategy was based on the estimation
of effective degrees of freedom [8], which provides an
analysis of covariance among HUFS SNPs in the extracted
LD block that was based on CEU HapMap samples. We
feel this approach better describes the relationship of SNPs
in LD within the queried window instead of assuming the
very conservative approach of independent effects for all
tested SNPs.
We also acknowledge the limitation of our study of
about 1,000 participants to detect some of the very small
effect sizes reported by the MAGIC study, which included
more than 122,000 participants. However, this study had
over 80% power to replicate similar effect sizes for 10 of
the 14 SNPs reported by the MAGIC study (ESM Table 3);
this is evident in this study’s ability to replicate several of
the published GWAS variants for FPG. We caution that lack
of replication in this study may be due to limited sample
size, differences in effect sizes calculated for SNPs and
difference in allele frequency between populations of
European and African ancestries.
The need for understanding differential susceptibility to
diseases at the population level makes the identification of
risk factors for diabetes and its indicators, including FPG,
particularly important in the African-American community
and other ethnic groups, given their disproportionate rate of
morbidity and mortality from diabetes and associated
complications. Unfortunately and for multiple reasons, the
majority of GWASs aimed at identifying genetic variants
associated with FPG and diabetes have so far focused
predominantly on individuals of European ancestry. While
the results from these studies provided tremendous insight
into the genetic architecture of the disease, recent studies of
non-European populations have shown utility in expanding
the breadth of populations studied. Specifically, studies in
East Asians allowed for a ‘wider net’ to be cast in the
identification of type 2 diabetes susceptibility variants [4, 11].
The present study’s focus on individuals self-identified as
African-Americans not only widens the net but also under-
scores the need for directed investigation of under-
represented populations.
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